Cookies

Like most websites The Translational Scientist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Diagnostics & prognostics

Tools & Techniques Diagnostics & prognostics

A Nose for Cancer

| Jonathan James

Could a multi-layer graphene (MLG)-based biomarker sensor offer the sensitivity needed for earlier lung cancer detection?

Tools & Techniques Diagnostics & prognostics

Getting to the Heart of the Matter

| Jonathan James

How a combinatorial approach to assessing coronary heart disease could improve diagnosis.

Tools & Techniques Diagnostics & prognostics

Biomarkers Beyond Our Wildest Dreams

| Luke Turner

Different glycosylation patterns in patients with idiopathic REM sleep behavior disorder could predict the future onset of neurodegenerative disease.

Disease Area Cancer

Load Versus Response

| Jonathan James

Higher tumor mutational burden is linked to improved survival across multiple cancer types.

Disease Area Neurological

Alzheimer's Awakening

| Jonathan James

Changes in non-REM sleep may indicate early AD

Tools & Techniques Diagnostics & prognostics

IAs - ID'd

| Jonathan James

How the RNA transcriptome of circulating neutrophils could hold the key to identifying intracranial aneurysms – before they rupture.

Disease Area Infectious diseases

Managing Malaria with Smarter Sampling

| Jonathan James

How targeting subclinical populations with a rapid saliva test may aid in the quest to eradicate the disease.

Tools & Techniques Diagnostics & prognostics

Gone Fishing

| Michael Schubert

A magnetic wire inserted into a vein captures circulating tumor cells and cell-free tumor DNA

Tools & Techniques Cancer

Express Insight into Bladder Cancer

| Michael Schubert

Looking at miRNA expression levels may improve our ability to subtype bladder cancers and provide the most appropriate and effective treatment

Research Field Diagnostics & prognostics

Better Biomarkers for AD R&D

| Carlo Medici

For better diagnosis and monitoring of Alzheimer’s disease, as well as drug R&D, we need to move toward widespread use of MRI biomarker imaging.

Newsletter

Send me the latest from The Translational Scientist.

Sign up now

Sister Publications

You might be interested in our Sister Publications:

Register to The Translational Scientist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts

Register